These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Human synovial mast cells. I. Ultrastructural in situ and in vitro immunologic characterization. de Paulis A; Marinò I; Ciccarelli A; de Crescenzo G; Concardi M; Verga L; Arbustini E; Marone G Arthritis Rheum; 1996 Jul; 39(7):1222-33. PubMed ID: 8670335 [TBL] [Abstract][Full Text] [Related]
4. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. Columbo M; Horowitz EM; Botana LM; MacGlashan DW; Bochner BS; Gillis S; Zsebo KM; Galli SJ; Lichtenstein LM J Immunol; 1992 Jul; 149(2):599-608. PubMed ID: 1378071 [TBL] [Abstract][Full Text] [Related]
5. Anaphylactic- and calcium-dependent generation of prostaglandin D2 (PGD2), thromboxane B2, and other cyclooxygenase products of arachidonic acid by dispersed human lung cells and relationship to histamine release. Holgate ST; Burns GB; Robinson C; Church MK J Immunol; 1984 Oct; 133(4):2138-44. PubMed ID: 6206153 [TBL] [Abstract][Full Text] [Related]
6. The human heart as a shock organ in anaphylaxis. Marone G; Bova M; Detoraki A; Onorati AM; Rossi FW; Spadaro G Novartis Found Symp; 2004; 257():133-49; discussion 149-60, 276-85. PubMed ID: 15025396 [TBL] [Abstract][Full Text] [Related]
7. Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release. Stellato C; Cirillo R; de Paulis A; Casolaro V; Patella V; Mastronardi P; Mazzarella B; Marone G Anesthesiology; 1992 Nov; 77(5):932-40. PubMed ID: 1280014 [TBL] [Abstract][Full Text] [Related]
8. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells. Casolaro V; Meliota S; Marino O; Patella V; de Paulis A; Guidi G; Marone G J Pharmacol Exp Ther; 1993 Dec; 267(3):1375-85. PubMed ID: 7505332 [TBL] [Abstract][Full Text] [Related]
9. Co-culture of human lung-derived mast cells with mouse 3T3 fibroblasts: morphology and IgE-mediated release of histamine, prostaglandin D2, and leukotrienes. Levi-Schaffer F; Austen KF; Caulfield JP; Hein A; Gravallese PM; Stevens RL J Immunol; 1987 Jul; 139(2):494-500. PubMed ID: 2439587 [TBL] [Abstract][Full Text] [Related]
10. Protein Fv produced during vital hepatitis is a novel activator of human basophils and mast cells. Patella V; Bouvet JP; Marone G J Immunol; 1993 Nov; 151(10):5685-98. PubMed ID: 7693815 [TBL] [Abstract][Full Text] [Related]
11. Human heart mast cells: a definitive case of mast cell heterogeneity. Patella V; de Crescenzo G; Ciccarelli A; Marinò I; Adt M; Marone G Int Arch Allergy Immunol; 1995 Apr; 106(4):386-93. PubMed ID: 7536502 [TBL] [Abstract][Full Text] [Related]
12. Protein L. A bacterial Ig-binding protein that activates human basophils and mast cells. Patella V; Casolaro V; Björck L; Marone G J Immunol; 1990 Nov; 145(9):3054-61. PubMed ID: 1698870 [TBL] [Abstract][Full Text] [Related]
13. Human skin mast cells: their dispersion, purification, and secretory characterization. Benyon RC; Lowman MA; Church MK J Immunol; 1987 Feb; 138(3):861-7. PubMed ID: 2433332 [TBL] [Abstract][Full Text] [Related]
14. Characteristics of histamine release from cultured human mast cells. Igarashi Y; Kurosawa M; Ishikawa O; Miyachi Y; Saito H; Ebisawa M; Iikura Y; Yanagida M; Uzumaki H; Nakahata T Clin Exp Allergy; 1996 May; 26(5):597-602. PubMed ID: 8735874 [TBL] [Abstract][Full Text] [Related]
15. The role of basophils in allergic disease. Knol EF; Mul FP; Lie WJ; Verhoeven AJ; Roos D Eur Respir J Suppl; 1996 Aug; 22():126s-131s. PubMed ID: 8871057 [TBL] [Abstract][Full Text] [Related]
16. Phenotypic and functional characterization of mast cells derived from renal tumor tissues. Beil WJ; Füreder W; Wiener H; Grossschmidt K; Maier U; Schedle A; Bankl HC; Lechner K; Valent P Exp Hematol; 1998 Feb; 26(2):158-69. PubMed ID: 9472805 [TBL] [Abstract][Full Text] [Related]
17. IgE enhances Fc epsilon receptor I expression and IgE-dependent release of histamine and lipid mediators from human umbilical cord blood-derived mast cells: synergistic effect of IL-4 and IgE on human mast cell Fc epsilon receptor I expression and mediator release. Yamaguchi M; Sayama K; Yano K; Lantz CS; Noben-Trauth N; Ra C; Costa JJ; Galli SJ J Immunol; 1999 May; 162(9):5455-65. PubMed ID: 10228025 [TBL] [Abstract][Full Text] [Related]
18. Prolonged culture of mast cells with high-glucose medium enhances the Fc epsilon RI-mediated degranulation response and leukotriene C4 production. Kitahata Y; Nunomura S; Terui T; Ra C Int Arch Allergy Immunol; 2010; 152 Suppl 1():22-31. PubMed ID: 20523060 [TBL] [Abstract][Full Text] [Related]
19. Quantitation of tryptase, chymase, Fc epsilon RI alpha, and Fc epsilon RI gamma mRNAs in human mast cells and basophils by competitive reverse transcription-polymerase chain reaction. Xia HZ; Kepley CL; Sakai K; Chelliah J; Irani AM; Schwartz LB J Immunol; 1995 May; 154(10):5472-80. PubMed ID: 7730649 [TBL] [Abstract][Full Text] [Related]
20. Mouse bone marrow-derived mast cells cocultured with fibroblasts. Morphology and stimulation-induced release of histamine, leukotriene B4, leukotriene C4, and prostaglandin D2. Levi-Schaffer F; Dayton ET; Austen KF; Hein A; Caulfield JP; Gravallese PM; Liu FT; Stevens RL J Immunol; 1987 Nov; 139(10):3431-41. PubMed ID: 2445814 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]